379 related articles for article (PubMed ID: 3498818)
21. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
[TBL] [Abstract][Full Text] [Related]
22. MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.
Desai VG; Feuers RJ; Hart RW; Ali SF
Brain Res; 1996 Apr; 715(1-2):1-8. PubMed ID: 8739616
[TBL] [Abstract][Full Text] [Related]
23. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ
J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810
[TBL] [Abstract][Full Text] [Related]
24. Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium.
Luthman J; Jonsson G
Med Biol; 1986; 64(2-3):95-102. PubMed ID: 3489145
[TBL] [Abstract][Full Text] [Related]
25. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
Zuddas A; Fascetti F; Corsini GU; Piccardi MP
Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
[TBL] [Abstract][Full Text] [Related]
26. Increased midbrain dopaminergic cell activity following 2'CH3-MPTP-induced dopaminergic cell loss: an in vitro electrophysiological study.
Bernardini GL; Speciale SG; German DC
Brain Res; 1990 Sep; 527(1):123-9. PubMed ID: 1980838
[TBL] [Abstract][Full Text] [Related]
27. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes.
Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
Glia; 1992; 5(1):48-55. PubMed ID: 1311704
[TBL] [Abstract][Full Text] [Related]
28. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP
Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651
[TBL] [Abstract][Full Text] [Related]
29. Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Chiba K; Peterson LA; Castagnoli KP; Trevor AJ; Castagnoli N
Drug Metab Dispos; 1985; 13(3):342-7. PubMed ID: 2861994
[TBL] [Abstract][Full Text] [Related]
30. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
[TBL] [Abstract][Full Text] [Related]
31. Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Heikkila RE; Nicklas WJ; Duvoisin RC
Adv Neurol; 1987; 45():149-52. PubMed ID: 3103384
[No Abstract] [Full Text] [Related]
32. Acute peripheral catecholaminergic changes in rat after MPTP and MPP+ treatment.
Ambrosio S; Mahy N
Rev Esp Fisiol; 1989 Jun; 45(2):157-61. PubMed ID: 2570448
[TBL] [Abstract][Full Text] [Related]
33. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147
[TBL] [Abstract][Full Text] [Related]
34. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
Mizuno Y; Sone N; Saitoh T
J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
[TBL] [Abstract][Full Text] [Related]
35. Neuropharmacological manipulations with MPTP.
Barnes NJ; Bradbury AJ; Costall B; Domeney AM; Kelly ME; Naylor RJ
J Neural Transm Suppl; 1986; 20():47-63. PubMed ID: 3091761
[TBL] [Abstract][Full Text] [Related]
36. The effect of dithiocarbamates on neurotoxic action of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and on mitochondrial respiration chain.
Bachurin SO; Shevtzova EP; Lermontova NN; Serkova TP; Ramsay RR
Neurotoxicology; 1996; 17(3-4):897-903. PubMed ID: 9086513
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
Staal RG; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
[TBL] [Abstract][Full Text] [Related]
38. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone.
Yoshihara S; Ohta S
Arch Biochem Biophys; 1998 Dec; 360(1):93-8. PubMed ID: 9826433
[TBL] [Abstract][Full Text] [Related]
39. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
40. Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.
Di Monte DA; Wu EY; Delanney LE; Irwin I; Langston JW
J Pharmacol Exp Ther; 1992 Apr; 261(1):44-9. PubMed ID: 1560384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
